Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polidocanol Injectable Foam for Varicose Veins
NCT00758420Phase 3Completed
- Sponsor
- Boston Scientific Corporation
- Start
- Oct 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of 10XB101 in Varicose Veins (2 arms), sponsored by Boston Scientific Corporation. Primary endpoint: Absolute Change From Baseline Score for the VVSymQ (Total Score) at 8 weeks. Started Oct 2008; status: completed.
02
Drugs
10XB101
03
Conditions
Varicose Veins
Beyond the preview
Go deeper on NCT00758420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00758420.